TeriparatideGH BoosterSafety Rating 8/10
Primary research areaOsteoporosis at high fracture risk
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Research dose range20 mcg once daily SC
AdministrationSubcutaneous injection
Safety8/10 · FDA-approved (Forteo)
NCAA D1Not listed
Price Comparison
Compare vendors
No vendor pricing available for this peptide yet.
Overview
About Teriparatide
Mechanism of action
Recombinant PTH 1-34; anabolic bone building through osteoblast stimulation and activation
Safety profile
Orthostatic hypotension, leg cramps, osteosarcoma risk (black box warning) · Approved for osteoporosis; 2-year limit (animal osteosarcoma); well-characterized in humans
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops Teriparatide below your target.
Related pages